Bioanalysis Zone

Exact Mass MSE: An Attractive Option For Quantification in Discovery DMPK


In association with Waters Corporation, Bioanalysis Zone is pleased to present a series of topical webinars highlighting the important challenges and information needs facing the bioanalytical community.

The series commenced on 19th July with Robert Plumb and Stephen McDonald (Waters). In the presentation our global audience learnt how the use of exact mass QT of MS can detect, identify and quantify drugs and their metabolites, through the use of chemically intelligent informatics and exact mass MS techniques, including MSE, allowing for greater specificity and selectivity to drive productivity in DMPK studies.

More webinars in this series

Opportunities for ensuring compliance and managing change: A next-generation platform strategy for regulated pharmaceutical laboratories

Xevo TQ-S: Breaking Industry Barriers

Bioanalysis of Therapeutic and Endogenous Peptides: Understanding and Overcoming the Challenges of Working with Large Molecules

High-Definition MALDI MS Imaging: Full Integration of the Ion Mobility Dimension from Acquisition to Visualization

Resolving the Complexity of Proteomic Samples with Ion Mobility-Mass Spectrometry



Leave A Comment